Is Travoprost registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Travoprost, including Ravopro (0.04 mg/ml, Eye drops, SAR 43.05); TRAVATAN EYE DROP (0.004 µ/ml, Eye drops, SAR 46.30).

Is Travoprost approved by the US FDA?

Drugs@FDA lists 13 application product lines for Travoprost, including TRAVATAN Z (Prescription); TRAVOPROST (Prescription); TRAVOPROST (Prescription); TRAVOPROST (Prescription); TRAVOPROST (Prescription).

Is Travoprost authorised in the European Union?

EMA lists 2 centrally authorised medicines containing Travoprost: Travatan, Izba.

Are there safety signals or safety updates for Travoprost?

US FDA: 3 entries (latest 2026-01-27).

Active substance

Travoprost

SFDA 2
US FDA 13
EMA 2
Health Canada 4
US price lines 4
NHS prices 2
Safety 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Ravopro	0.04 mg/ml	Eye drops · Ocular use	1 Dropper Container	SAR 43.05	Generic · Prescription	Advanced Pharmaceutical Industries	Valid
TRAVATAN EYE DROP	0.004 µ/ml	Eye drops · Ocular use	1 Dropper Container	SAR 46.30	Generic · Prescription	NOVARTIS PHARMA AG	Valid

Indications — CHI Daman Drug Formulary

OPEN ANGLE GLUCOMA

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
TRAVATAN Z	0.004%	solution/drops · ophthalmic	SANDOZ	Prescription	21 Sep 2006
TRAVOPROST	0.004%	solution/drops · ophthalmic	CHARTWELL RX	Prescription	1 Mar 2013
TRAVOPROST	0.004%	solution/drops · ophthalmic	APOTEX	Prescription	10 Jul 2015
TRAVOPROST	0.004%	solution/drops · ophthalmic	MYLAN	Prescription	7 Jul 2017
TRAVOPROST	0.004%	solution/drops · ophthalmic	MICRO LABS	Prescription	19 Mar 2021
IDOSE TR	75MCG	implant · intracameral	GLAUKOS	Prescription	13 Dec 2023
TRAVOPROST	0.004%	solution/drops · ophthalmic	GLAND	Prescription	12 Jul 2024
TRAVOPROST	0.004%	solution/drops · ophthalmic	SOMERSET THERAPS LLC	Prescription	23 Sep 2024
TRAVOPROST	0.004%	solution/drops · ophthalmic	ALEMBIC	Prescription	17 Dec 2025
TRAVATAN	0.004% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	solution/drops · ophthalmic	ALCON PHARMS LTD	Discontinued	16 Mar 2001
IZBA	0.003% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	solution/drops · ophthalmic	NOVARTIS	Discontinued	15 May 2014
TRAVOPROST	0.004%	solution/drops · ophthalmic	ALEMBIC	Discontinued	20 Dec 2019
TRAVOPROST	0.004%	solution/drops · ophthalmic	LUPIN	Discontinued	3 May 2024

EMA European Union — centrally authorised medicines

Travatan Novartis Europharm Limited · Authorised · authorised 27 Nov 2001 · ATC S01EE04

Therapeutic indication (EMA)

Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma (see section 5.1).

Izba Novartis Europharm Limited · Authorised · authorised 20 Feb 2014 · ATC S01EE04

Therapeutic indication (EMA)

Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma (see section 5.1). Decrease of elevated intraocular pressure in paediatric patients aged 3 years to < 18 years with ocular hypertension or paediatric glaucoma.

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
IZBA	02457997	0.003 % / W/V	SOLUTION · OPHTHALMIC	NOVARTIS PHARMACEUTICALS CANADA INC
JAMP TRAVOPROST Z	02548089	0.004 % / W/V	SOLUTION · OPHTHALMIC	JAMP PHARMA CORPORATION
SANDOZ TRAVOPROST	02413167	0.004 % / W/V	SOLUTION · OPHTHALMIC	SANDOZ CANADA INCORPORATED
TRAVATAN Z	02318008	0.004 % / W/V	SOLUTION · OPHTHALMIC	NOVARTIS PHARMACEUTICALS CANADA INC

Prices — United States and England

Source	Product as listed	Price	Unit / pack	Date
US NADAC	TRAVATAN Z 0.004% EYE DROP	$94.2313	per ML	23 Sep 2026
US NADAC	TRAVATAN Z 0.004% EYE DROP	$94.29844	per ML	23 Sep 2026
US NADAC	TRAVOPROST 0.004% EYE DROP	$8.39412	per ML	23 Sep 2026
US NADAC	TRAVOPROST 0.004% EYE DROP	$9.74746	per ML	23 Sep 2026
NHS Drug Tariff	Travoprost 40micrograms/ml eye drops	£2.29	2.5 ml	1 Oct 2026
NHS Drug Tariff	Travoprost 40micrograms/ml eye drops 0.1ml unit dose preservative free	£7.49	30 unit dose	1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

US FDA 27 Jan 2026 IDOSE TR — safety-related labeling change
Labeling sections changed: Warnings and Precautions
US FDA 9 Jun 2021 IZBA — safety-related labeling change
Labeling sections changed: Adverse Reactions; Use in Specific Populations
US FDA 2 Apr 2020 TRAVATAN Z — safety-related labeling change
Labeling sections changed: Adverse Reactions; Use in Specific Populations

All safety entries for travoprost →

Combinations containing Travoprost

Timolol + travoprost

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.